Evidence map›Paper›PMID 38865965›Full record

ArticleImmunity2024

Poking holes in the blood-brain barrier.

Xiyu Ma, Judy Lieberman

Abstract readComment
In one paragraph

Article in Immunity, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Xiyu MaProgram in Cellular and Molecular Medicine, Boston Children's Hospital, and Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA. Electronic address: xiyu.ma@childrens.harvard.edu.
Judy LiebermanProgram in Cellular and Molecular Medicine, Boston Children's Hospital, and Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA. Electronic address: judy.lieberman@childrens.harvard.edu.

Funding

Gasdermin E and pyroptosis in cancerR01CA240955 · NCI · BOSTON CHILDREN'S HOSPITAL · PI LIEBERMAN, JUDY · 2020 to 2024
$2.5M
Lipidomic and Transcriptome Signatures in Aspirin-Exacerbated Respiratory DiseaseR21AI082369 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI BOYCE, JOSHUA A · 2009 to 2010
$487k
NCI NIH HHS R01 CA240955NIAID NIH HHS R21 AI082369
6 · The paper itself

Abstract

Bacterial lipopolysaccharide (LPS) is implicated in disrupting the blood-brain barrier (BBB). In a recent issue of Nature, Wei et al. now show that LPS activates the inflammatory caspases (4, 5, and 11) and gasdermin D (GSDMD) in brain endothelial cells, which triggers their pyroptotic cell death and disrupts the BBB.

Indexed as

Blood-Brain BarrierEndothelial CellsLipopolysaccharidesAnimalsCaspasesHumansIntracellular Signaling Peptides and ProteinsMicePhosphate-Binding ProteinsPyroptosisCaspasesIntracellular Signaling Peptides and ProteinsLipopolysaccharidesPhosphate-Binding Proteins

Identifiers

PMID38865965
PMCPMC11495843

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.